| 000 | 01062 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250513035318.0 | ||
| 264 | 0 | _c19950926 | |
| 008 | 199509s 0 0 eng d | ||
| 022 | _a0065-1427 | ||
| 024 | 7 |
_a10.1111/j.1600-0404.1995.tb05857.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEbers, G C | |
| 245 | 0 | 0 |
_aImmunotherapy for MS: clinical aspects and trials. _h[electronic resource] |
| 260 |
_bActa neurologica Scandinavica. Supplementum _c1995 |
||
| 300 |
_a54 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterferon beta-1a |
| 650 | 0 | 4 | _aInterferon beta-1b |
| 650 | 0 | 4 |
_aInterferon-beta _xtherapeutic use |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xtherapy |
| 700 | 1 | _aSibley, W A | |
| 700 | 1 | _aPaty, D W | |
| 773 | 0 |
_tActa neurologica Scandinavica. Supplementum _gvol. 161 _gp. 54 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1600-0404.1995.tb05857.x _zAvailable from publisher's website |
| 999 |
_c7652676 _d7652676 |
||